Olmesartan-Mepha Teva 40 mg, Filmtabletten - 28 Swissmedic Key 68523005 Registration Holder Mepha Pharma AG Name Olmesartan-Mepha Teva 40 mg, Filmtabletten Date of registration 08.06.2022 Original/Generic Generic Introduction of Sequence 08.06.2022 ATC-Classification Olmesartan Medoxomil (C09CA08) Revision date WHO WHO-DDD Valid until 07.06.2027 Index Therapeuticus (BSV) 02.07.10. Show package size 28 Index Therapeuticus (Swissmedic) 02.07.10. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 16.97 Limitation No Deductible 10 % Consumer price 35.90 Feedback FB Daily cost GTIN 7680685230058 Medication Code Synthetika Pharmacode Disponibility
Composition olmesartanum medoxomilum 40.0 mg, lactosum monohydricum 302.12 mg, hydroxypropylcellulosum substitutum humile, hydroxypropylcellulosum, cellulosum microcristallinum, magnesii stearas, Überzug: hypromellosum, titanii dioxidum, lactosum monohydricum 2.77 mg, macrogolum 3350, triacetinum, pro compresso obducto. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Olmesartanum Medoxomilum 40 mg
BAG: Active Agent Dose Olmesartan Medoxomil 40 mg
Inactive agents Dose additional_information Cellulosum Microcristallinum Hydroxypropylcellulosum Hydroxypropylcellulosum Substitutum Humile Hypromellosum Überzug Lactose Monohydrate 2.77 mg Macrogol 3350 Magnesii Stearas Pro Compresso Obducto Titanium Dioxide Triacetinum
Source Data was imported : 06.07.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
